Table 1.
Clinical characteristics of patients with COVID-19.
| Characteristic | Total (n = 373) |
Non-severe (n = 322) |
Severe (n = 51) |
p value |
|---|---|---|---|---|
| Age, n (%) | ||||
| ⩽39 | 128 (34.32) | 121 (37.58) | 7 (13.73) | 0.0010** |
| 40–49 | 62 (16.62) | 55 (17.08) | 7 (13.73) | 0.5500 |
| 50–59 | 67 (17.96) | 60 (18.63) | 7 (13.73) | 0.3960 |
| 60–69 | 77 (20.64) | 63 (19.57) | 14 (27.45) | 0.1960 |
| 70–79 | 32 (8.58) | 21 (6.52) | 11 (21.57) | 0.0010** |
| ⩾80 | 7 (1.88) | 2 (0.62) | 5 (9.80) | 0.0001*** |
| Male | 197 (52.82) | 168 (52.17) | 29 (56.86) | 0.0390* |
| Days from illness onset to admission days | 5.191 (3.651) | 5.249 (3.751) | 4.824 (2.951) | 0.4400 |
| Hospitalization days | 17.48 (8.702) | 16.51 (7.560) | 23.61 (12.33) | <0.0001**** |
| Comorbidity, n (%) | ||||
| Any | 128 (34.32) | 104 (32.30) | 24 (47.06) | 0.0390* |
| Hypertension | 71 (19.03) | 59 (18.32) | 12 (23.53) | 0.3790 |
| Cardiovascular disease | 18 (4.83) | 12 (3.73) | 6 (11.76) | 0.0130* |
| Diabetes | 29 (7.77) | 21 (6.52) | 8 (15.69) | 0.0466* |
| COPD | 4 (1.07) | 2 (0.62) | 2 (3.92) | 0.0920 |
| Chronic liver disease | 14 (3.75) | 10 (3.11) | 4 (7.84) | 0.2086 |
| Others | 29 (7.77) | 24 (7.45) | 5 (9.80) | 0.7634 |
| Symptoms, n (%) | ||||
| Fever | 184 (48.33) | 156 (48.45) | 28 (54.90) | 0.3920 |
| Cough | 127 (34.05) | 106 (32.92) | 21 (41.18) | 0.2480 |
| Headache | 18 (4.83) | 15 (4.66) | 3 (5.88) | 0.9782 |
| Sputum production | 78 (20.91) | 64 (19.88) | 14 (27.45) | 0.2160 |
| Diarrhea | 22 (5.90) | 20 (6.21) | 2 (3.92) | 0.7452 |
| Muscle pain | 34 (9.12) | 31 (9.63) | 3 (5.88) | 0.7990 |
| Chills and rigors | 22 (5.90) | 7 (2.17) | 15 (29.41) | <0.0001**** |
| Fatigue | 54 (14.48) | 41 (12.73) | 13 (25.49) | 0.0160* |
| Anorexia | 18 (4.83) | 12 (3.73) | 6 (11.76) | 0.0326* |
Data was presented as mean (SD).
*
p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
COVID-19, coronavirus disease 2019; COPD, chronic obstructive pulmonary disease.